Skip to main content
. 2020 Nov 13;6(4):388–398. doi: 10.1001/jamacardio.2020.6566

Table 1. Baseline Characteristics of Study Participants by Tertile West African Ancestry.

Characteristic Patients, No. (%) P value for trend
Tertile 1 (n = 882) Tertile 2 (n = 817) Tertile 3 (n = 767)
West African ancestry, % (IQR) 69 (63-74) 81 (79-83) 89 (87-92)
APOL1 risk count <.001
0 411 (46.6) 326 (39.9) 274 (35.7)
1 385 (43.7) 376 (46.0) 343 (44.7)
2 86 (9.8) 115 (14.1) 150 (19.6)
Intensive treatment arm 436 (49.4) 386 (47.2) 388 (50.6) .40
Age, mean (SD), y 65.2 (9.1) 63.2 (8.7) 64.3 (9.0) <.001
Female 393 (44.6) 368 (45.0) 361 (47.1) .57
College education 532 (60.2) 435 (53.2) 381 (49.7) <.001
No insurance 135 (15.3) 168 (20.6) 144 (18.8) .02
Blood pressure, mm Hg
Systolic 140 (16.4) 140 (16.0) 140 (16.1) .84
Diastolic 80 (12.7) 82 (12.2) 81 (12.2) .01
BMI 31 (6.1) 31 (6.4) 31 (6.5) .19
Chronic kidney disease 187 (21.2) 185 (22.6) 201 (26.2) .05
Clinical cardiovascular disease 101 (11.5) 84 (10.3) 76 (9.9) .56
Atrial fibrillation 44 (5.0) 35 (4.3) 30 (3.9) .55
Heart failure 31 (3.5) 37 (4.5) 37 (4.8) .38
Peripheral vascular disease 43 (4.9) 34 (4.2) 41 (5.4) .53
Stroke 3 (0.3) 7 (0.9) 4 (0.5) .36
Diabetes 13 (1.5) 10 (1.2) 21 (2.7) .05
Hypertension 832 (94.3) 775 (94.9) 721 (94.0) .76
Depression 149 (16.9) 138 (16.9) 127 (16.6) .98
Alcohol abuse 51 (5.8) 44 (5.4) 42 (5.5) .93
Family history of heart disease
No 323 (36.7) 323 (39.5) 302 (39.5) .43
Yes 486 (55.2) 428 (52.4) 390 (51.0)
Unknown 72 (8.2) 66 (8.1) 73 (9.5)
Smoking
Never 372 (42.2) 348 (42.6) 367 (47.9) .01
Former 320 (36.3) 259 (31.7) 225 (29.4)
Current 189 (21.5) 210 (25.7) 174 (22.7)
Blood urea nitrogen, mean (SD), mg/dL 17.3 (6.6) 17.2 (6.4) 17.6 (7.2) .37
Cholesterol, mean (SD), mg/dL 195.6 (41.9) 197.5 (42.4) 195.7 (38.7) .57
Chloride, mean (SD), mEq/L 103.1 (2.7) 103.3 (2.9) 103.1 (2.7) .49
Bicarbonate, mean (SD), mEq/L 26.3 (2.8) 26.3 (2.8) 26.5 (2.6) .39
Urine creatinine, mean (SD), mmol 155.5 (94.1) 155.2 (88.2) 155.2 (89.8) .99
Glucose, mean (SD), mg/dL 97.9 (13.9) 97.7 (16.0) 97.6 (17.5) .94
High-density lipoprotein cholesterol, mean (SD), mg/dL 54.2 (14.9) 54.8 (15.1) 56.5 (15.0) .01
Potassium, mean (SD), mEq/L 4.1 (0.4) 4.0 (0.4) 4.1 (0.4) .20
Low-density lipoprotein cholesterol, mean (SD), mg/dL 118.9 (35.0) 121.1 (37.0) 118.4 (34.8) .26
Sodium, mean (SD), mEq/L 140.4 (2.3) 140.4 (2.2) 140.5 (2.2) .26
Triglycerides, mean (SD), mg/dL 115.2 (115.6) 112.7 (131.7) 105.9 (69.5) .21
Urine microalbumin-creatinine ratio, mean (SD), μg/mg 36.7 (113.8) 61.6 (263.8) 45.9 (140.8) .02
Creatinine, mg/dL 1.1 (0.4) 1.1 (0.4) 1.2 (0.4) .01
Estimated glomerular filtration rate, mean (SD), mL/min/1.73 m2 77.9 (23.1) 76.7 (22.8) 74.0 (22.8) .003
QRS duration, mean (SD), ms 92.7 (16.1) 92.0 (16.1) 91.8 (16.0) .50
Cornell voltage, mean (SD), mV 1701.5 (715.3) 1677.5 (733.8) 1739.9 (724.2) .23
Left ventricular hypertrophy by Cornell voltage (baseline) 95 (10.8) 103 (12.6) 120 (15.6) .01
Framingham 10-y cardiovascular disease risk, mean (SD) 18.1 (10.2) 17.2 (9.9) 16.7 (9.7) .01
No. of antihypertensive drugs at start, mean (SD), % 2.0 (1.1) 2.0 (1.0) 2.0 (1.0) .73
Aspirin 373 (42.4) 317 (38.8) 317 (41.3) .32
Statin 323 (36.8) 260 (32.0) 243 (31.9) .05

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); IQR, interquartile range.

SI conversion factors: To convert blood urea nitrogen to mmol/L, multiply by 0.357; high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and total cholesterol to mmol/L, multiply by 0.0259; chloride, bicarbonate, potassium, and sodium to mmol/L, multiply by 1.0; glucose to mmol/L, multiply by 0.0555; triglycerides to mmol/L, multiply by 0.0113; creatinine to μmol/L, multiply by 88.4.